Seer, Inc. (SEER)
NASDAQ: SEER · IEX Real-Time Price · USD
2.155
+0.035 (1.65%)
May 2, 2024, 3:59 PM EDT - Market closed
Seer, Inc. Revenue
In the year 2023, Seer, Inc. had annual revenue of $16.66M with 7.54% growth. Revenue in the quarter ending December 31, 2023 was $4.44M, a -3.63% decrease year-over-year.
Revenue (ttm)
$16.66M
Revenue Growth
+7.54%
P/S Ratio
8.16
Revenue / Employee
$113,340
Employees
147
Market Cap
139.91M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 16.66M | 1.17M | 7.54% |
Dec 31, 2022 | 15.49M | 8.88M | 134.14% |
Dec 31, 2021 | 6.62M | 5.96M | 908.69% |
Dec 31, 2020 | 656.00K | 540.00K | 465.52% |
Dec 31, 2019 | 116.00K | - | - |
Dec 31, 2018 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
So-Young International | 211.29M |
InterCure | 112.41M |
Biodesix | 49.09M |
Scilex Holding Company | 46.74M |
Augmedix | 44.86M |
Zomedica | 25.19M |
MSP Recovery | 7.71M |
SEER News
- 9 days ago - Seer to Report First Quarter 2024 Financial Results on May 8, 2024 - GlobeNewsWire
- 2 months ago - Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook - GlobeNewsWire
- 2 months ago - Seer to Participate in the TD Cowen 44th Annual Health Care Conference - GlobeNewsWire
- 3 months ago - Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery - GlobeNewsWire
- 3 months ago - Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 - GlobeNewsWire
- 4 months ago - Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference - GlobeNewsWire
- 6 months ago - Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum - GlobeNewsWire
- 6 months ago - Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500 - GlobeNewsWire